B.V. Sinn

SPARC expression in resected pancreatic cancer patients treated with gemcitabine: results from the CONKO-001 study

M. Sinn, B.V. Sinn, Jana K. Striefler et al. · Annals of Oncology · 2014 · 76 citations · Full text

Medicine, Oncology, Surgery +9

Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemcitabine – Results from the CONKO-001 trial

M. Sinn, Hanno Riess, B.V. Sinn et al. · European Journal of Cancer · 2015 · 50 citations

Medicine, Cancer Biology, Oncology +8

Radiation-induced apoptosis in human non-small-cell lung cancer cell lines is secondary to cell-cycle progression beyond the G2-phase checkpoint

Martin Stuschke, Ali Sak, R. Wurm et al. · International Journal of Radiation Biology · 2002 · 29 citations · Full text

Medicine, Cell Biology, Oncology +15

Abstract S1-06: Increased tumor-associated lymphocytes predict benefit from addition of carboplatin to neoadjuvant therapy for triple-negative and HER2-positive early breast cancer in the GeparSixto trial (GBG 66)

Carsten Denkert, Sibylle Loibl, Christoph Salat et al. · Cancer Research · 2013 · 23 citations

Medicine, Oncology, Pharmacology +17

Abstract PD2-07: mRNA signatures predict response to durvalumab therapy in triple negative breast cancer (TNBC)– Results of the translational biomarker programme of the neoadjuvant double-blind placebo controlled GeparNuevo trial

Sibylle Loibl, B.V. Sinn, Thomas Karn et al. · Cancer Research · 2019 · 14 citations

Medicine, Cancer Biology, Oncology +17